Outreach Plan for Biodesign Sample Clauses

Outreach Plan for Biodesign. Work Package: 1 Due date of deliverable: Month 6 Actual submission date: 30.11.2016 Start date of project: June 01 2016 Duration: 36 months Lead beneficiary for this deliverable: Xxxxx Xxxx (UPD), Xxxxx Xxxxxxxxx, Xxxx Xxxxx Xxxxxx (MP) Contributors: Xxxx Xxxx (UPD), Xxxxx Xxxxxxxx, Xxxxxxxxx Xxxx (UCL), Xxxxxxx Xxxx, Xxxxxx xxx Xxxxxxxx (WS), Xxxxxxx Xxxxx (ECSA), Xxxxx Xxxxx, Xxxxx Xxxxxxx (KI), Xxxxx Xxxxxxxxxxx (Meritum), Xxxx Xxxx Xxxxxxxxx-Xxxxxxx, Xxxxxx Xxxxxxx (UNIGE), Xxxxxxxxxx Xxxxxxxxxxxxxxx (Tekiu) Reviewer: Xxxxx Xxxxxxxx (UNIGE) Project co-funded by the European Commission within the H2020 Programme (2014-2020) PU Public X CO Confidential, only for members of the consortium (including the Commission Services) EU- RES Classified Information: RESTREINT UE (Commission Decision 2005/444/EC) EU- CON Classified Information: CONFIDENTIEL UE (Commission Decision 2005/444/EC) EU- SEC EU-SEC Classified Information: SECRET UE (Commission Decision 2005/444/EC) This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 709443 Disclaimer The content of this deliverable does not reflect the official opinion of the European Union. Responsibility for the information and views expressed herein lies entirely with the author(s). All ‘Doing It Together science’ (DITOs) consortium members are also committed to publish accurate and up to date information and take the greatest care to do so. However, the DITOs consortium members cannot accept liability for any inaccuracies or omissions nor do they accept liability for any direct, indirect, special, consequential or other losses or damages of any kind arising out of the use of this information. Copyright Notice This work by Parties of the DITOs Consortium is licensed under a Creative Commons Attribution 4.0 International License (xxxx://xxxxxxxxxxxxxxx.xxx/licenses/by/4.0/).
AutoNDA by SimpleDocs

Related to Outreach Plan for Biodesign

  • Curriculum Development This includes the analysis and coordination of textual materials; constant review of current literature in the field, some of which are selected for the college library collection, the preparation of selective, descriptive materials such as outlines and syllabi; conferring with other faculty and administration on curricular problems; and, the attendance and participation in inter and intra-college conferences and advisory committees.

  • Curriculum Vitae (a) The Chief Librarian shall maintain a curriculum vita for each Librarian. It is the Librarian’s responsibility to ensure that the curriculum vita on file is kept current. Members shall prepare their curriculum vita with the advice and assistance of their Chief Librarian. Members may revise their curriculum vita at any time.

  • Promotional Materials In the event that the Fund or the Adviser makes available any promotional materials related to the Securities or the transactions contemplated hereby intended for use only by registered broker-dealers and registered representatives thereof by means of an Internet web site or similar electronic means, the Adviser will install and maintain, or will cause to be installed and maintained, pre-qualification and password-protection or similar procedures which are reasonably designed to effectively prohibit access to such promotional materials by persons other than registered broker-dealers and registered representatives thereof.

  • Supplier Diversity Seller shall comply with Xxxxx’s Supplier Diversity Program in accordance with Appendix V.

  • Promotional Material In the event that the Fund or the Investment Adviser makes available any promotional materials related to the Securities or the transactions contemplated hereby intended for use only by registered broker-dealers and registered representatives thereof by means of an Internet web site or similar electronic means, the Investment Adviser will install and maintain or will cause to be installed and maintained, pre-qualification and password-protection or similar procedures which are reasonably designed to effectively prohibit access to such promotional materials by persons other than registered broker-dealers and registered representatives thereof.

  • Research Design The data generated by excavations at the prehistoric site(s) will be used to examine at least three topics: (1) chronology; (2) technology; and (3) subsistence practices. Insights into changing patterns of community organization may also be granted, as may insights into changes in social organization. The data recovered will then be compared to data from other regional sites.

  • Program Development NWESD agrees that priority in the development of new applications services by XXXXX shall be in accordance with the expressed direction of the XXXXX Board of Directors operating under their bylaws.

  • Educational Program a. The educational program of the School (Section 4, Subsection 6 from the original contract and unchanged here) is as follows:

  • Product Safety Seller must maintain the state of the product so that it is able to perform to its designed or intended purpose without causing unacceptable risk of harm to a person or damage to property.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. How to File an Expedited Appeal Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.

Time is Money Join Law Insider Premium to draft better contracts faster.